Condition
Carrier State
Total Trials
6
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Recruiting4
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06847256RecruitingPrimary
Genetic Risk Factor for Heat Stroke
NCT05474417RecruitingPrimary
The Effects of the CF Carrier State on the Kidneys and Pancreas
NCT05474430RecruitingPrimary
Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
NCT06831110Recruiting
Aquagenic Wrinkling Prediction
NCT04431934Not ApplicableUnknownPrimary
Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL)
NCT00153556Phase 4Completed
Study to Eliminate Hib Carriage in Rural Alaska Native Villages
Showing all 6 trials